USANA Health Sciences, Inc.
USNA · NYSE
12/28/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $680 | $1,032 | $1,024 | $2,039 |
| - Cash | $182 | $330 | $288 | $240 |
| + Debt | $39 | $13 | $14 | $17 |
| Enterprise Value | $538 | $715 | $750 | $1,816 |
| Revenue | $855 | $921 | $999 | $1,186 |
| % Growth | -7.2% | -7.8% | -15.8% | – |
| Gross Profit | $693 | $744 | $805 | $969 |
| % Margin | 81.1% | 80.8% | 80.6% | 81.6% |
| EBITDA | $99 | $123 | $130 | $193 |
| % Margin | 11.6% | 13.4% | 13% | 16.3% |
| Net Income | $42 | $64 | $69 | $117 |
| % Margin | 4.9% | 6.9% | 6.9% | 9.8% |
| EPS Diluted | 2.19 | 3.3 | 3.59 | 5.73 |
| % Growth | -33.6% | -8.1% | -37.3% | – |
| Operating Cash Flow | $61 | $71 | $104 | $121 |
| Capital Expenditures | -$10 | -$14 | -$10 | -$13 |
| Free Cash Flow | $51 | $56 | $94 | $108 |